⏰ Tomorrow, April 21, is the FINAL day to take advantage of discounted pricing for ASPET 2026 - the pharmacology event of the year! You don’t want to miss the opportunity to save up to $150 on registration fees before prices go up. Register now and save: https://www.aspet.org/aspet2026/registration
Yimei Wang, a 4th-year PhD candidate, is the Drug Metabolism and Disposition HTA for April 2026. Her research utilizes in vivo fermentation with tRNA scaffold and tRNA-fused pre-miRNA carrier technologies to produce novel recombinant miRNA molecule: https://doi.org/10.1016/j.dmd.2026.100292
Announcing the ASPET Leadership Academy! Make sure you're ready for a leadership position with this webinar series, dedicated to preparing health sciences professionals for leadership roles. Learn more and register: https://ow.ly/QrMi50YIg36
#pharmsky 🧪
Are you ready to take an active role in shaping the future of pharmacology and toxicology? Drug Metabolism and Disposition is seeking a new Editor-in-Chief. Learn more about the position and application: https://dmd.aspetjournals.org/news
#pharmsky 🧪
Each month, JPET selects a featured article that is free-to-read. This month we're proud to present "Pharmacogenetic influence on bupropion bioactivation and clinical outcomes in major depressive disorder." Read and share this important research: https://ow.ly/Clij50YFK64
#pharmsky 🧪
Traci Czyzyk, PhD, MBA and Marcus Delatte, PhD, highlights how strong mentor-mentee relationships can shape career growth by providing guidance, confidence, and valuable professional connections: thepharmacologist.org/industry-insights-mar-20...
You have until August 31 to submit your work to Molecular Pharmacology's upcoming special collection, which celebrates the world-leading research showcased by attendees of the 5th Transatlantic ECI GPCR Symposium. Learn more: https://ow.ly/CGTm50YGvB9
#pharmsky 🧪
Meet the early-career scientists, Sherouk Tawfik and Sadikshya Aryal who have been highlighted in the March 2026 issue of The Pharmacologist. Learn what drives them and why their research is important to them.
➡️ Read "On Their Way..." here: https://thepharmacologist.org/on-their-way-mar-2026/
Interested in publishing or reading research articles pertinent to Clinical Pharmacology? This editorial, from JPET's editor-in-chief Beverley Greenwood-Van Meerveld and associate editor Giorgio Minotti, explains the journal's newest section: https://ow.ly/LYbS50YF0Mq
#pharmsky 🧪
Are you considering a career change, or have you or your colleagues been affected by recent transformations at the federal, academic, or industry level? Learn about different career trajectories, meet potential mentors and mentees, and more at ASPET 2026!
🔗 https://ow.ly/aOwG50YEtwT
Andersen et al. quantitatively determined the efficiencies of 3 major RNases in various rat tissues and subcellular fractions in metabolizing RNAs, enabling the development of new RNA therapeutics. Read DMD's Editor's Choice to learn more: https://ow.ly/hGkp50YEFUj
#pharmsky 🧪
Researchers at the UT-San Antonio Health Science Center are developing a new mu opioid receptor antagonist that shows promise as a next‑generation overdose antidote. Read about their research in this issue's Editor's Choice of JPET: https://ow.ly/q3fa50YAUrv 🧪#pharmsky
Alex White, PhD, is the Molecular Pharmacology HTA for April 2026. His research focuses on understanding the signaling mechanisms of GPCR that underlie their biology with the hopes that these insights can be exploited to develop novel therapies: https://doi.org/10.1016/j.molpha.2026.100111
Inspired by ASPET President Randy Hall’s article on artificial intelligence and its potential impact on pharmacology, Executive Officer Dave Jackson discusses how ASPET is - and has been - providing content focused on AI for its members: thepharmacologist.org/note-from-daves-desk-mar...
Researchers from Emory University have identified negative allosteric modulators for the GluN1/GluN3A receptor. This could enable a better understanding of those receptors in health and disease. Learn more in Molecular Pharmacology's Editor's Choice: https://ow.ly/zonV50YAUXy
#pharmsky 🧪
Scientists come to ASPET's annual meeting to hear from distinguished keynote speakers and learn about recent breakthroughs. But science happens through connection, and ASPET 2026 offers a number of unique ways for you to connect with your colleagues! https://ow.ly/HU6s50YAGH3 🧪
Interested in learning about the development of a drug that could help patients recover after a stroke or TBI? Read the Editor's Choice in the recent issue of The Journal of Pharmacology and Experimental Therapeutics: jpet.aspetjournals.org/article/S0022-3565(26)00... 🧪#pharmsky
Randy Hall, PhD, discusses how AI could transform biomedical research, not as a replacement for scientists but as a powerful collaborator. In the next few decades, researchers who master this partnership may ultimately define the next era of biomedical discovery: https://ow.ly/rksH50YAGfJ
Dive into the pioneering work of Dr. William Coley, whose controversial experiments using bacterial toxins to trigger immune responses led to unexpected cancer remissions, earning him recognition as the “Father of Cancer Immunotherapy.”
🔗https://thepharmacologist.org/william-coley/
ICYMI: Teresa K. Woodruff, PhD, an internationally recognized reproductive biologist, will speak at ASPET 2026! Hear the story of how her research efforts in ovarian follicle culture led her to think about potential applications of the technology.
🧪 https://www.aspet.org/ASPET2026/Registration
JPET has launched a new research article section: Clinical Pharmacology! This new section will let investigators show their talent in designing and conducting clinical pharmacokinetic/pharmacodynamic studies. Learn more about how you can contribute your work: https://ow.ly/hTYt50YykYE
#pharmsky 🧪
The deadline has been extended to August 31 for Molecular Pharmacology's upcoming special collection, which celebrates the world-leading research showcased by attendees of the 5th Transatlantic ECI GPCR Symposium. Learn more: https://ow.ly/5sy350Ywmev
🧪#pharmsky
There’s still time to register for the remaining Spring Division Town Halls! Learn about the divisions' latest activities and how to get involved, get a sneak peek of ASPET 2026 presentations, and network with colleagues and peers.
🔗 Register: https://ow.ly/6sLq50Ywh53
Sadikshya Aryal, a 5th-year PhD candidate, is the Molecular Pharmacology Highlighted Trainee Author for March 2026. Her research focuses on understanding how a key signaling enzyme in the nervous system, called AC1, is regulated inside cells.
🔗 https://doi.org/10.1016/j.molpha.2026.100101
Attendees will learn how to maximize their job search strategy with AI, use prompts to identify transferable skills and target roles, leverage LinkedIn for networking and informational interviews, and more: https://ow.ly/FxhZ50YvTIL
#pharmsky 🧪
Check our our featured article in Drug Metabolism and Disposition, free to read for a limited time: https://ow.ly/vZvR50Yw1Cx 🧪
Meet Nobel Laureate Peter Agre, MD, at ASPET 2026! He will describe the human aquaporins (AQP0 – AQP12) and their functions, as well as discuss his work in public health and science diplomacy.
🧪 Register to learn from Dr. Agre and other experts: https://www.aspet.org/ASPET2026/Registration
Trying to land a job in pharmacology? Sign up for TODAY's online workshop and learn how to maximize job search strategies with AI! https://ow.ly/AIv550YuLFw
Check out this featured article, recently published in the Journal of Pharmacology and Experimental Therapeutics and free-to-read for a limited time! Written by Sherouk M. Tawfik, Le Tra Giang Nguyen, Jing Jin, Beshoy Armanios, and Xiao-bo Zhong: https://ow.ly/mtop50YtzhQ
Dr. Ashim Malhotra, Program Director of the IDEA Faculty Scholars and several of its participants reflect on the program and share feedback on their projects.
➡️IDEA: One Year Later: thepharmacologist.org/idea-faculty-scholars-fe...
